Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119863) titled 'A real-world prospective observational study on the efficacy and safety of L-AmB for breakthrough IFD in children and adolescent patients with hematological malignancies receiving triazoles or echinocandins prophylaxis' on March 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.
Condition:
Invasive fungal disease
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-29
Target Sample Size: L-AmB therapy:43;
Countries of Recruitment:...